Merck & Co Inc
NYSE: MRK
$96.82
Real Time Data Delayed 15 Min.
MRK Articles
Jon Ogg24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see which ones investors are more excited about this earnings season. This is a...
Published:
Last Updated:
ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke,...
Published:
Last Updated:
Jon OggShort sellers have kept their attack up against the high-dividend stocks, perhaps indicating that many investors believe that the bull market may turn back toward growth rather than paying a...
Published:
Jon OggShort sellers have continued to by and large increase their short-sale bets against the quality high-yield dividend stocks. The price gains must lead short sellers to believe that the yields...
Published:
U.S. equity markets opened lower this morning following news out of China that government is about to tighten restrictions on real estate transactions. The news pushed the Shanghai exchange down...
Published:
Last Updated:
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) raised to Neutral at J.P....
Published:
Last Updated:
Jon OggShort sellers have increased their bets by and large against our universe of go-to quality dividend stocks. We tracked the short interest changes from the February 15 settlement date, versus...
Published:
Jon OggShort sellers have had their challenges due to rising share prices since the start of 2013. They have gone on to make some serious changes in the high dividend stocks now that the dividend tax...
Published:
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Last Updated:
U.S. equity markets opened lower this morning as concerns about European markets reared up again. The U.K.’s PMI came in lower than expected and consumer confidence was lower, sending equities...
Published:
Last Updated:
Jon OggThese are this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Broadcom Corp. (NASDAQ: BRCM) reiterated Buy with $46 target at Argus....
Published:
Last Updated:
ThinkstockCorporate governance issues are sometimes a blessing for shareholders, but they also can crush the rights of shareholders in many cases. Tracking CEO pay of large public companies is now...
Published:
U.S. equity markets opened higher this morning on the heels of a solid report on U.S. nonfarm payrolls, which rose less than expected but on top of a large upward revision for December (more coverage...
Published:
Last Updated:
ThinkstockZoetis Inc. (NYSE: ZTS), a spin-off of the animal health business of Pfizer Inc. (NYSE: PFE), held its initial public offering this morning. The company offered 86.1 million shares at $26 a...
Published:
Last Updated:
U.S. equity markets opened lower this morning following a mixed bag of data on the U.S. economy and mixed earnings results out this morning. In Europe, Germany’s retail sales fell sharply this...
Published:
Last Updated: